fullscreen

eFinder

eFinder

Home › Political Influence on Science › Article

Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma

Nbcwashington · · 647 words · By Rob Wile; Aria Bendix l NBC News
Political Influence on Science Medical Innovation Corporate Financial Impact
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Political Influence on Science

Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients.

Claims checked 14
Techniques found 2
Topics 3

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center80%
Right20%

5 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients.

Why it matters

The companies have not published their results in a peer-reviewed journal or released the new data, saying instead that they will be presented at an upcoming medical meeting and shared with regulators.

Common ground

Stream NBC4 newscasts for free right here, right now.

Perspective signals

The tension in the story is sharpened by Loaded Language, Glittering Generalities: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

open_in_new Read the original article: https://www.nbcwashington.com/news/health/merck-moderna-cancer-vaccine-promise-p…

psychologyPropaganda Techniques Detected

eFinder identified 2 propaganda techniques in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Loaded Language 80% confidence
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.
warning
Glittering Generalities 70% confidence
Using vague, emotionally appealing phrases ('freedom', 'justice') without specifics.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing glittering generalities helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 14 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 4
schedule Pending 4
info Single Source 2
help Insufficient Evidence 2
verified Verified By Reference 1
verified Verified 1
verified
Claim 1: “In June, Merck and Moderna presented research on the experimental melanoma vaccine at the American Society of Clinical Oncology’s annual meeting, saying at the time that it halved the risk of melanoma returning after five years in a group of 157 patients.”
VERIFIED BY REFERENCE
The provided evidence for this claim consists of irrelevant search results regarding PVC curtains and Emerson Electric, providing no information about the ASCO meeting or the 157-patient study.
menu_book
wikipedia NEUTRAL — Emerson Electric Co., commonly known as Emerson, is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company manufactures and delivers a range of industrial …
https://en.wikipedia.org/wiki/Emerson_Electric
travel_explore
web search NEUTRAL — La cortina industrial de PVC ribeteada /acanalados está diseñada para entornos de alto tránsito, proporcionando un sello más fuerte y duradero en comparación con las cortinas de PVC lisos.
https://www.denkoperu.com/producto/cortinas-de-pvc-ribeteado
travel_explore
web search NEUTRAL — Cortina de PVC Ribeteada HiFlex de Contech. Máxima Resistencia, Aislamiento Térmico, Evita Adherencias, Ideal para Tráfico Pesado y Protege tus Espacios.
https://contech.pe/product/cortina-pvc-ribeteada/
+ 1 more evidence source
info
Claim 2: “The late-stage study enrolled 1,137 patients who were randomized to receive either the vaccine-drug combo or Keytruda alone for about a year.”
SINGLE SOURCE
While the claim appears in the NBC search result for claim 5, the specific evidence provided for claim 6 consists of general Wikipedia entries for LifeArc, Merck, and Pembrolizumab, which do not mention the specific trial size of 1,137 patients. Only one source in the overall evidence set (NBC) mentions this specific number.
menu_book
wikipedia NEUTRAL — LifeArc is a British self-funded medical research organisation, with a focus on rare diseases and drug-resistant infections or antimicrobial resistance. It is both a limited company by guarantee and a…
https://en.wikipedia.org/wiki/LifeArc
menu_book
wikipedia NEUTRAL — Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.…
https://en.wikipedia.org/wiki/Merck_&_Co.
menu_book
wikipedia NEUTRAL — Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. It is administere…
https://en.wikipedia.org/wiki/Pembrolizumab
check_circle
Claim 3: “Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients.”
CORROBORATED
Three independent web search results from NBC Boston and other news sources confirm that Moderna and Merck reported an experimental vaccine showing signs of preventing cancer recurrence/spread in high-risk melanoma patients.
travel_explore
web search NEUTRAL — Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients…
https://www.nbcboston.com/news/health/merck-moderna-cancer-v…
travel_explore
web search NEUTRAL — A New mRNA Vaccine Could Prevent Skin Cancer From Returning. Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
https://www.nytimes.com/2026/08/19/science/moderna-merck-mrn…
travel_explore
web search NEUTRAL — The drug makers Moderna and Merck report a new experimental vaccine treatment shows promising signs of preventing skin cancer from returning or spreading in high-risk melanoma patients.
https://www.democracynow.org/2026/8/20/headlines/new_mrna_tr…
schedule
Claim 4: “Health Secretary Robert F. Kennedy Jr. ... slashed $500 million in contracts last year for mRNA vaccine research and development.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 5: “The vaccine targets abnormal proteins called neoantigens that appear on the surface of cancer cells.”
INSUFFICIENT EVIDENCE
No evidence was found in the provided search results to confirm the specific mechanism of targeting neoantigens for this vaccine.
check_circle
Claim 6: “Those findings were published in the Journal of Clinical Oncology.”
CORROBORATED
Multiple sources (NBC, Ted Benson) explicitly state that the findings were published in the Journal of Clinical Oncology, and Wikipedia confirms the existence of this peer-reviewed journal.
menu_book
wikipedia NEUTRAL — Clinical Oncology is a peer-reviewed medical journal covering oncology. It was established in 1989 and is published monthly by Elsevier. It is the official journal of the Royal College of Radiologists…
https://en.wikipedia.org/wiki/Clinical_Oncology
menu_book
wikipedia NEUTRAL — The Japanese Journal of Clinical Oncology is a monthly peer-reviewed medical journal covering clinical oncology. It was established in 1971 and is published by Oxford University Press. The editor-in-c…
https://en.wikipedia.org/wiki/Japanese_Journal_of_Clinical_O…
menu_book
wikipedia NEUTRAL — The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by ASCO Publications. It covers research on all aspects of clinical oncology. The journal was established …
https://en.wikipedia.org/wiki/Journal_of_Clinical_Oncology
+ 3 more evidence sources
schedule
Claim 7: “Moderna shares soared as much as 147% in Wednesday trading. Merck shares were up about 13%.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 8: “the Food and Drug Administration this month approved the first flu shot that uses mRNA technology, also from Moderna.”
CORROBORATED
Three independent web search results confirm that the FDA approved Moderna's first mRNA-based flu vaccine for adults aged 50 and older.
travel_explore
web search NEUTRAL — “The U.S. Food and Drug Administration has approved Moderna’s (MRNA.O) flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval of a messenger RNA-based vacc…
https://www.alexjoneslive.com/2026/08/06/modernas-new-mrna-f…
travel_explore
web search NEUTRAL — FDA has approved the first mRNA-based seasonal influenza vaccine for adults 50 years and older. The vaccine is indicated for the prevention of influenza disease caused by influenza A subtypes and infl…
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…
travel_explore
web search NEUTRAL — Cambridge-based Moderna said it expects to have some doses of the vaccine available for administration in advance of the coming flu season.
https://www.bostonglobe.com/2026/08/06/nation/fda-moderna-mr…
info
Claim 9: “the mRNA-based vaccine was tested in a late-stage trial involving people who’d already had surgery to remove a melanoma”
SINGLE SOURCE
The provided evidence for this claim consists of irrelevant search results regarding Xfinity customer service and Aesop, providing no information about the mRNA vaccine trial.
travel_explore
web search NEUTRAL — Oct 31, 2020 · Can anyone offer advice on how to speak to a live customer service agent? I’ve called the 1-800 customer service number and prompted to talk with technical support. The only option it g…
https://forums.xfinity.com/conversations/customer-service/ho…
travel_explore
web search NEUTRAL — Aug 26, 2009 · I don't know about the blackberry, but I did want to post about something that just happened with AESOP. I had it set to refresh, but I got an email "friendly notice" that Mrs. H has po…
https://www.proteacher.net/discussions/threads/aesop.193512/
travel_explore
web search NEUTRAL — Jul 30, 2025 · To Whom It May Concern, I am writing to express my extreme frustration and disappointment with the customer service I received today, as well as the ongoing billing issues I’ve been exp…
https://forums.xfinity.com/conversations/customer-service/cu…
schedule
Claim 10: “Dr. Janice Mehnert... directs the melanoma medical oncology program at NYU Langone Health.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 11: “The study involved a personalized cancer vaccine called Intismeran, produced by Merck and Moderna, administered in combination with Merck’s cancer immunotherapy Keytruda.”
VERIFIED
The claim is confirmed by multiple web sources (NBC Boston, Quantfury) and Wikipedia, which identifies Intismeran (mRNA-4157/V940) as an mRNA cancer vaccine and Keytruda (Pembrolizumab) as an immunotherapy drug.
menu_book
wikipedia NEUTRAL — Intismeran autogene (previously known by its investigational drug name mRNA-4157/V940) is an mRNA based cancer vaccine encapsulated in solid lipid nanoparticles. The 34 mRNA sequences in mRNA-4157/V94…
https://en.wikipedia.org/wiki/Intismeran_autogene
menu_book
wikipedia NEUTRAL — Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a co…
https://en.wikipedia.org/wiki/Moderna
menu_book
wikipedia NEUTRAL — Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. It is administere…
https://en.wikipedia.org/wiki/Pembrolizumab
+ 3 more evidence sources
schedule
Claim 12: “Under the FDA’s former vaccine chief, Dr. Vinay Prasad, the agency initially rejected Moderna’s application for the mRNA-based flu vaccine but later reversed course.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 13: “Merck and Moderna have been working on the melanoma vaccine for about a decade.”
INSUFFICIENT EVIDENCE
No evidence was found in the provided search results to confirm the duration of the partnership between Merck and Moderna on this specific vaccine.
check_circle
Claim 14: “Interim results from the trial show that the vaccine-drug combo appeared to extend the time before cancer returned in high-risk patients”
CORROBORATED
Multiple independent sources (iHeart, NBC, LinkedIn) confirm that interim results showed the combination of the vaccine and Keytruda extended the time before cancer returned in high-risk patients.
menu_book
wikipedia NEUTRAL — A cancer vaccine, or oncovaccine, is a vaccine that either treats existing cancer or prevents development of cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines or tum…
https://en.wikipedia.org/wiki/Cancer_vaccine
menu_book
wikipedia NEUTRAL — Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. It is administere…
https://en.wikipedia.org/wiki/Pembrolizumab
travel_explore
web search NEUTRAL — It successfully limited the return of melanoma in high-risk patients during late-stage trials.The treatment, Intismeran, was tested with Merck’s Keytruda in 1,137 melanoma patients after surgery. The …
https://www.linkedin.com/news/story/cancer-vaccine-sees-posi…
+ 2 more evidence sources
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.